• Deutsch
  • English



Innovation is our business

DIOPTEX was founded in 2003 by Dr. Albert Daxer as a research and development enterprise for medicine / ophthalmology / eye surgery in Linz, Austria. In the meantime, DIOPTEX has grown to become a global technology leader in the treatment of ectatic eye diseases such as keratoconus, post-LASIK keratectasia, complicated myopia and inadequate outcomes after corneal transplantation. With KERALUX, MyoRing and PocketMaker, DIOPTEX has developed medicinal products which establish a new standard in the treatment of the mentioned eye diseases. These products are milestones in modern eye surgery and have decisively enhanced treatment efficacy. During the past years thousands of patients suffering from severe loss of vision by these diseases have been successfully prevented from blindness and their vision have been permanently restored by our technology.

Excellence at the highest international level

The core competencies of DIOPTEX include: international top-level research and development in the fields of medical engineering and life sciences; consulting; development of complex medicinal products up to the establishment of industry-level production; production and distribution logistics; quality management including ISO 13485 (medical devices); approval of medical devices for use on humans; implementation of the technology for medical applications under standard clinical conditions; medical expertise at international leadership level; in-depth market knowledge in medical application areas of the relevant technology; international patent law; establishment of distribution structures; and international sales.

Dr. Albert Daxer

Dr. Daxer is the founder and managing partner of DIOPTEX. He is a passionate ophthalmologist and researcher and an internationally acclaimed eye surgeon specialising in laser surgery, corneal surgery and keratoconus.

After being trained in electrical communications engineering and electronics at a polytechnic high school (HTL), he completed his military service and then worked as a development engineer in the semiconductor industry. Subsequently, he earned an academic degree (Dipl.-Ing. (TU)) in technical physics at the Vienna University of Technology. After a short period of industrial activity in the field of laser technology, he began to study medicine at the University of Vienna and eventually earned his medical degree (Dr.med.univ.). Alongside his medical studies, he worked as a physicist at the Institute for Experimental Physics and at the Research Centre for Intensive Care Medicine at the University of Vienna, as well as at the Seibersdorf Research Centre. He then completed his specialist training in ophthalmology and optometry at the University Hospital of Innsbruck, where he also gained his habilitation and where he is a senior lecturer (Univ.-Doz.) authorised to teach ophthalmology. In addition to his technical and medical education, Dr. Daxer also completed a stockbroker training and holds a corresponding licence for the Vienna Stock Exchange.

His research activities encompass the entire field of ophthalmology, with a special focus on laser and corneal surgery as well as keratoconus. He has published a number of basic research papers on the biomechanics, structure and transparency of the cornea as well as on the genesis, ultrastructural changes and surgical treatment of keratoconus in various scientific journals of international acclaim. He is one of the world‘s leading researchers in the field. He is also a regular reviewer in internationally renowned journals in his field of expertise and holds numerous international patents.

In addition to his business DIOPTEX, Dr. Daxer runs a general ophthalmology practice in Wieselburg (Austria), an eye laser centre in Wels (Austria) together with six colleagues, as well as keratoconus therapy centres in Wieselburg (Austria) and Munich (Germany). He is also engaged in the global training of ophthalmologists in state-of-the-art keratoconus treatment.